Globus Medical (GMED) Tops Q4 EPS by 5c

Globus Medical (NYSE: GMED) reported Q4 EPS of $0.30, $0.05 better than the analyst estimate of $0.25. Revenue for the quarter came in at $128.8 million versus the consensus estimate of $127.77 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS
• Rochon family buys $100M in AIAI Holdings shares at $20 each